financetom
Business
financetom
/
Business
/
--Applied Materials Guides For Q3 EPS of $1.83-$2.19 on Revenue of $6.65 Billion, +/- $400 Million, vs CIQ Analyst Consensus of $1.97/Share on Revenue of $6.58 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Applied Materials Guides For Q3 EPS of $1.83-$2.19 on Revenue of $6.65 Billion, +/- $400 Million, vs CIQ Analyst Consensus of $1.97/Share on Revenue of $6.58 Billion
May 16, 2024 1:39 PM

04:03 PM EDT, 05/16/2024 (MT Newswires) --

Price: 210.10, Change: -4.07, Percent Change: -1.90

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ibex Expands Call Center Operations in Honduras
Ibex Expands Call Center Operations in Honduras
Oct 10, 2024
01:19 PM EDT, 10/08/2024 (MT Newswires) -- Ibex (IBEX) said Tuesday it has added nearly 10,000 square feet to call center facility in Tegucigalpa, Honduras. The company said the addition increased the capacity by 35% with over 180 new production seats. The expanded operations are expected to create nearly 250 jobs. The expanded facility became operational in mid-September, and Ibex...
GSK shares seen opening higher after settlement of 80,000 Zantac lawsuits
GSK shares seen opening higher after settlement of 80,000 Zantac lawsuits
Oct 9, 2024
(Reuters) - Shares of GSK are seen rising 5% according to pre-market indications on Thursday after the British drugmaker agreed to pay up to $2.2 billion to settle lawsuits that claimed its discontinued heartburn drug Zantac caused cancer. The agreement, announced on Wednesday, resolved 80,000 or 93% of the pending cases against the company in the U.S. and was far...
UBS 'bang on target' with Credit Suisse integration, IT chief says
UBS 'bang on target' with Credit Suisse integration, IT chief says
Oct 9, 2024
ZURICH (Reuters) - UBS's integration of former rival Credit Suisse's clients and data with its own platforms is bang on target after a successful test run, its tech chief told Reuters. UBS CEO Sergio Ermotti has previously flagged that IT integration is one of the biggest risks facing UBS as it embarks on the second, trickier phase of merging with...
Viking Therapeutics Unusual Options Activity
Viking Therapeutics Unusual Options Activity
Oct 10, 2024
Investors with a lot of money to spend have taken a bullish stance on Viking Therapeutics ( VKTX ) . And retail traders should know. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know. But when something this...
Copyright 2023-2026 - www.financetom.com All Rights Reserved